|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-12-24
|
|
pubmed:abstractText |
Darbepoetin alfa is the second erythropoietic protein to be approved for the treatment of chemotherapy-induced anemia (CIA). In the clinical setting, darbepoetin alfa can be administered less frequently than epoetin alfa with similar efficacy. Practice patterns and outcomes associated with the use of darbepoetin alfa and epoetin alfa in the clinical setting have not been reported.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2781-96
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14693304-Aged,
pubmed-meshheading:14693304-Aged, 80 and over,
pubmed-meshheading:14693304-Anemia,
pubmed-meshheading:14693304-Antineoplastic Agents,
pubmed-meshheading:14693304-Drug Administration Schedule,
pubmed-meshheading:14693304-Drug Utilization Review,
pubmed-meshheading:14693304-Erythropoietin,
pubmed-meshheading:14693304-Female,
pubmed-meshheading:14693304-Hematinics,
pubmed-meshheading:14693304-Humans,
pubmed-meshheading:14693304-Male,
pubmed-meshheading:14693304-Middle Aged,
pubmed-meshheading:14693304-Neoplasms,
pubmed-meshheading:14693304-Physician's Practice Patterns,
pubmed-meshheading:14693304-Recombinant Proteins,
pubmed-meshheading:14693304-Retrospective Studies
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia.
|
|
pubmed:affiliation |
Supportive Oncology Services, Inc., The West Clinic, Memphis, Tennessee 38120, USA. lschwartzberg@westclinic.com
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
